Johnson & Johnson, a global healthcare giant, is recalling more of its metal-on-metal hip implants in international markets. According to Handelsblatt, a German newspaper, the company is currently in the process of recalling its Adept hip replacement system. A report by the Associated Press notes that the failure rate for the Adept metal-on-metal hip implant system is 12 percent after seven years.
Between 2004 and 2011, Johnson & Johnson distributed approximately 7,500 Adept metal-on-metal hip implants around the world. The Adept MoM total hip system and hip resurfacing systems were acquired in 2009 by DePuy Orthopedics, a subsidiary of Johnson & Johnson, from Finsbury Orthopaedic, a medical device manufacturer based in the United Kingdom.
This latest recall is one of many issues at the company. Johnson & Johnson’s high-profile recall of its ASR metal-on-metal hip implant led to many lawsuits and poor investor confidence. The recall of the company’s ASR MoM hip implants was started in 2010 “due to the number of patients who required a second hip replacement procedure, called a revision surgery.” One report showed that an estimated 37 percent of the company’s ASR MoM hip implants would require replacement or revision after less than five years.
- How to Develop a Risk Based Biological Safety Evaluation Per New US FDA Guidance - Webcast
- 3 Tips for Successfully Launching an Outsourced Medical Device - Webcast
- When Do I Really Need to Perform an Ethylene Oxide Requalification? - Webcast
- Rapid Prototyping for Medical Devices - Webcast
- New Approaches to Assessing Biocompatibility for Medical Devices - Webcast
- Five Mistakes That Can Derail Your Product Development Effort - Webcast